{"id":875833,"date":"2025-08-14T10:34:34","date_gmt":"2025-08-14T14:34:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/"},"modified":"2025-08-14T10:34:34","modified_gmt":"2025-08-14T14:34:34","slug":"gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/","title":{"rendered":"GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <em>Live video webcast on Wednesday, August 20<\/em><br \/>\n        <sup><br \/>\n          <em>th<\/em><br \/>\n        <\/sup><br \/>\n        <em> at 2:20 PM ET <\/em>\n      <\/p>\n<p align=\"justify\">\n        <strong>LA JOLLA, CA, Aug.  14, 2025  (GLOBE NEWSWIRE) &#8212; <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EA_rxh9L5oTDpBj2eT0AOf3o5vhevJZhhv2b1bLHeiaXl7_2EnOEfP9tulV2fo6oUe8M2n2omkxMblm7EXHSWg==\" rel=\"nofollow\" target=\"_blank\">GRI Bio, Inc.<\/a> (NASDAQ: GRI) (\u201cGRI Bio\u201d or the \u201cCompany\u201d), a biotechnology company advancing an innovative pipeline of Natural Killer T (\u201cNKT\u201d) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, that it will present at the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Nee5qEJg00OG8kZPK4mGhKJNaIxylUWckEtWbzfjSUHkKsZvWitycCKhno2iS2Ey5VJ1Qr3RoBGx7R0ApR35FSzkxMxpD8o5hYjfZ9v1u1vIjOPlrbyfsOA_OIiCIV21zGKAZ8XAllm1H2xlM0WtuO7G-y8kbC2ZjeRs5QFRJyw=\" rel=\"nofollow\" target=\"_blank\">Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech<\/a> being held virtually August 19-21, 2025.<\/p>\n<p>Details for the presentation are as follows:<\/p>\n<p>\n        <strong>Date and Time:<\/strong> Wednesday, August 20, 2025 at 2:20 PM ET<br \/><strong>Presenter:<\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FxncayXU6G0ULFdRAzVQDU095w9z4Eiofya1e7z1x-1cw31gQBrR267XaDANWNpkiOADz_J8Bv90BaIzpK_7U5BNYDhge8ue82Q8_U2yBT9oZjvWq6h-evVaGWyxb9gioKj55VYHmYONTOX1hpjL8Y5uyf8umrzYS_ZJH4hCxZxOsBeriVkeDpWMkJPY4q-q\" rel=\"nofollow\" target=\"_blank\">Marc Hertz, PhD, President, Chief Executive Officer and Director<\/a><br \/><strong>Registration Link:<\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OME_L_AoRXB70OyNStyTWMRYjQiMc3G57Sth6qSF3DJBLK3N579Acg3VVXT2ztMYWxdrwQ18Ik21cNHgXUHAhA==\" rel=\"nofollow\" target=\"_blank\">HERE<\/a><\/p>\n<p>\n        <strong>About Webull Financial\u00a0<\/strong>\n      <\/p>\n<p align=\"justify\">Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading on a wide range of assets, advanced charting tools, and real-time market data, Webull is revolutionizing the way individuals approach investing. The user-centric approach and commitment to staying at the forefront of industry trends underscore the mission to provide a seamless and rewarding experience for traders of all levels. Through the Webull Group, Webull Financial and its affiliates combine to serve tens of millions of users from over 180 countries worldwide. Securities and futures trading is offered to customers by Webull Financial LLC (&#8220;Webull Financial&#8221;), a broker-dealer registered with the Securities and Exchange Commission (SEC) and a futures commission merchant registered with the Commodity Futures Trading Commission (CFTC). Webull Financial is a member of the Financial Industry Authority (FINRA), the National Futures Association (NFA), and the Securities Investor Protection Corporation (SIPC). All investing is subject to risk, including the possible loss of principal. For more information about Webull, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ee_ug6r9m--GiUOuD_uBcaSwAbVUHH36eV5q-q7xT444a_QOUdTkQoKnfQsuvfafW9DCCRLXlXnNm9eeRPPayw==\" rel=\"nofollow\" target=\"_blank\">www.webull.com<\/a>.<\/p>\n<p>\n        <strong>About GRI Bio, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">GRI Bio is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI Bio\u2019s therapies are designed to target the activity of Natural Killer T (\u201cNKT\u201d) cells, which are key regulators earlier in the inflammatory cascade, to interrupt disease progression and restore the immune system to homeostasis. NKT cells are innate-like T cells that share properties of both NK and T cells and are a functional link between the innate and adaptive immune responses. Type I invariant NKT (\u201ciNKT\u201d) cells play a critical role in propagating the injury, inflammatory response, and fibrosis observed in inflammatory and fibrotic indications. GRI Bio\u2019s lead program, GRI-0621, is an inhibitor of iNKT cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis, a serious disease with significant unmet need. The Company is also developing a pipeline of novel type 2 diverse NKT (\u201cdNKT\u201d) agonists for the treatment of systemic lupus erythematosus. Additionally, with a library of over 500 proprietary compounds, GRI Bio has the ability to fuel a growing pipeline.<\/p>\n<p align=\"justify\">\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>JTC Team, LLC<br \/>Jenene Thomas<br \/>(908) 824-0775<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_JLiCdxKAzC8LQcg9dj7oh96NO3MZRxvH4vonZlViLlDlFNzT6zJiIRhqLvn1AO672kwIufZyWW-4gEdJBaQJw==\" rel=\"nofollow\" target=\"_blank\">GRI@jtcir.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMjYyNiM3MTAwMDAyIzUwMDA3NTQ4OA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZmRlZDcwOTctZTg1ZC00ODQwLTg5ZTctYjAzNjc3YTU2Y2EzLTUwMDA3NTQ4OC0yMDI1LTA4LTE0LWVu\/tiny\/GRI-Bio-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Live video webcast on Wednesday, August 20 th at 2:20 PM ET LA JOLLA, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) &#8212; GRI Bio, Inc. (NASDAQ: GRI) (\u201cGRI Bio\u201d or the \u201cCompany\u201d), a biotechnology company advancing an innovative pipeline of Natural Killer T (\u201cNKT\u201d) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech being held virtually August 19-21, 2025. Details for the presentation are as follows: Date and Time: Wednesday, August 20, 2025 at 2:20 PM ETPresenter:Marc Hertz, PhD, President, Chief Executive Officer and DirectorRegistration Link:HERE About Webull Financial\u00a0 Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-875833","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Live video webcast on Wednesday, August 20 th at 2:20 PM ET LA JOLLA, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) &#8212; GRI Bio, Inc. (NASDAQ: GRI) (\u201cGRI Bio\u201d or the \u201cCompany\u201d), a biotechnology company advancing an innovative pipeline of Natural Killer T (\u201cNKT\u201d) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech being held virtually August 19-21, 2025. Details for the presentation are as follows: Date and Time: Wednesday, August 20, 2025 at 2:20 PM ETPresenter:Marc Hertz, PhD, President, Chief Executive Officer and DirectorRegistration Link:HERE About Webull Financial\u00a0 Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and &hellip; Continue reading &quot;GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-14T14:34:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMjYyNiM3MTAwMDAyIzUwMDA3NTQ4OA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\\\/MedTech\",\"datePublished\":\"2025-08-14T14:34:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/\"},\"wordCount\":483,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxMjYyNiM3MTAwMDAyIzUwMDA3NTQ4OA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/\",\"name\":\"GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\\\/MedTech - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxMjYyNiM3MTAwMDAyIzUwMDA3NTQ4OA==\",\"datePublished\":\"2025-08-14T14:34:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxMjYyNiM3MTAwMDAyIzUwMDA3NTQ4OA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxMjYyNiM3MTAwMDAyIzUwMDA3NTQ4OA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\\\/MedTech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/","og_locale":"en_US","og_type":"article","og_title":"GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech - Market Newsdesk","og_description":"Live video webcast on Wednesday, August 20 th at 2:20 PM ET LA JOLLA, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) &#8212; GRI Bio, Inc. (NASDAQ: GRI) (\u201cGRI Bio\u201d or the \u201cCompany\u201d), a biotechnology company advancing an innovative pipeline of Natural Killer T (\u201cNKT\u201d) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech being held virtually August 19-21, 2025. Details for the presentation are as follows: Date and Time: Wednesday, August 20, 2025 at 2:20 PM ETPresenter:Marc Hertz, PhD, President, Chief Executive Officer and DirectorRegistration Link:HERE About Webull Financial\u00a0 Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and &hellip; Continue reading \"GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-14T14:34:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMjYyNiM3MTAwMDAyIzUwMDA3NTQ4OA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech","datePublished":"2025-08-14T14:34:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/"},"wordCount":483,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMjYyNiM3MTAwMDAyIzUwMDA3NTQ4OA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/","name":"GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMjYyNiM3MTAwMDAyIzUwMDA3NTQ4OA==","datePublished":"2025-08-14T14:34:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMjYyNiM3MTAwMDAyIzUwMDA3NTQ4OA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMjYyNiM3MTAwMDAyIzUwMDA3NTQ4OA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gri-bio-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech\/MedTech"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/875833","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=875833"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/875833\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=875833"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=875833"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=875833"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}